Lexpos News

Drug alert number: EL (24)A/44 Date issued: 30 September 2024 Pfizer Limited is recalling all distributed batches of Oxbryta 500 mg Tablets. Pfizer Limited has informed the MHRA that the product is being withdrawn due to emerging data from clinical trials and registry-based studies: Oxbryta (voxelotor) 500mg Tablets (Pfizer Limited) PLGB 00057/1720 DMRC Number: DMRC-32749585 [...]

The post MHRA Class 2 Medicines Recall: Oxbryta (voxelotor) 500mg Tablets (Pfizer Limited) appeared first on Community Pharmacy England.

From next week, Tuesday 1 October, references will no longer be required for market entry applications. This followed concerns raised by Community Pharmacy England that they offered little value to the process and contributed to delays. The changes are included in The National Health Service (Pharmaceutical and Local Pharmaceutical Services) (Amendment) (No. 2) Regulations 2024 [...]

The post Market Entry application change – no references required appeared first on Community Pharmacy England.

DHSC has informed us that, following the General Election where the progress of these amendments was paused, they are briefing new ministers across all policy areas, including hub and spoke dispensing between different pharmacy owners. As this will take time, they are now not in a position to implement these proposals from 1 January 2025, [...]

The post DHSC Hub and Spoke Update appeared first on Community Pharmacy England.

The Department of Health and Social Care (DHSC) has confirmed that sufficient stock of Cefalexin 500mg tablets are now available to meet normal demand. As a result the Serious Shortage Protocol (SSP), SSP072 Cefalexin 500mg tablets expires at 23.59pm on Friday 27 September 2024. After this date, any prescriptions for Cefalexin 500mg tablets must be [...]

The post Expiry of SSP072 Cefalexin 500mg tablets appeared first on Community Pharmacy England.

Community Pharmacy England on behalf of pharmacy owners made further applications to the Department of Health and Social Care (DHSC) and the NHS Business Services Authority (NHSBSA), resulting in a further 15 new products being added to the ‘Drugs for which Discount is Not Deducted’ (DND) list from 1 October 2024. This takes the total [...]

The post 15 products added to the Discount Not Deducted (DND) list from October 2024 appeared first on Community Pharmacy England.